HomeComparePKI vs BTI

PKI vs BTI: Dividend Comparison 2026

PKI yields 0.24% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTI wins by $18.1K in total portfolio value
10 years
PKI
PKI
● Live price
0.24%
Share price
$115.24
Annual div
$0.28
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.02
Full PKI calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — PKI vs BTI

📍 BTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPKIBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PKI + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PKI pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PKI
Annual income on $10K today (after 15% tax)
$20.65/yr
After 10yr DRIP, annual income (after tax)
$0.02/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, BTI beats the other by $2,381.93/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PKI + BTI for your $10,000?

PKI: 50%BTI: 50%
100% BTI50/50100% PKI
Portfolio after 10yr
$28.8K
Annual income
$1,401.15/yr
Blended yield
4.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PKI right now

PKI
Analyst Ratings
13
Buy
18
Hold
Consensus: Hold
Price Target
$166.57
+44.5% upside vs current
Range: $145.00 — $202.00
Altman Z
2.9
Piotroski
7/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PKI buys
0
BTI buys
13
PoliticianChamberTickerTypeAmountDate
Lisa McClain🏢 House$BTI▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$BTI▲ Buy$1,001 - $15,0002025-08-04
Lisa McClain🏢 House$BTI▼ Sell$1,001 - $15,0002025-06-24
Lisa McClain🏢 House$BTI▲ Buy$1,001 - $15,0002025-06-17
Daniel Goldman🏢 House$BTI▼ Sell$50,001 - $100,0002023-07-10
Daniel Goldman🏢 House$BTI▲ Buy$15,001 - $50,0002023-02-27
Daniel Goldman🏢 House$BTI▼ Sell$50,001 - $100,0002023-01-13
Virginia Foxx🏢 House$BTI▼ Sell$50,001 - $100,0002022-11-02
Virginia Foxx🏢 House$BTI▲ Buy$1,001 - $15,0002022-08-23
Virginia Foxx🏢 House$BTI▲ Buy$1,001 - $15,0002022-07-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPKIBTI
Forward yield0.24%5.40%
Annual dividend / share$0.28$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%11.3%
Portfolio after 10y$19.7K$37.8K
Annual income after 10y$0.02$2,802.29
Total dividends collected$24.00$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$166.57$40.00

Year-by-year: PKI vs BTI ($10,000, DRIP)

YearPKI PortfolioPKI Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$10,712$12.15$11,301$601.08$589.00BTI
2$11,468$6.08$12,799$706.58$1.3KBTI
3$12,274$3.04$14,527$832.38$2.3KBTI
4$13,135$1.52$16,527$982.75$3.4KBTI
5$14,055$0.76$18,846$1,162.95$4.8KBTI
6$15,039$0.38$21,545$1,379.49$6.5KBTI
7$16,092$0.19$24,694$1,640.41$8.6KBTI
8$17,218$0.10$28,378$1,955.69$11.2KBTI
9$18,424$0.05$32,702$2,337.79$14.3KBTI
10$19,713$0.02$37,794$2,802.29$18.1KBTI

PKI vs BTI: Complete Analysis 2026

PKIStock

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Full PKI Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PKI vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PKI vs SCHDPKI vs JEPIPKI vs OPKI vs KOPKI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.